Nice I've got wow and ccl. Rfg is another that did very well in...

First 5 Last

Share
Profile

Follow
zhanginu

554 Posts.

9

06/09/15

16:41

Post #: 15943794
Share

Originally posted by chadshare ↑

Bought both CCL and WOW after their recent down turns. Both stocks have structural issues with Coke affected by CSD decline and WOW by low cost competitors. I prefer CCL as they are implementing a systematic and so far effective plan of non coke product roll out with the blue sky but problematic Indonesian operations.
Australia has a high probability of entering into recession in the next 12 to 24 months, which has been priced into the currency devaluation we are experiencing. This is why I believe defensive stocks with large dividends are preferential to" growth stocks" on high multiples or those dependent on discretionary spending. Both WOW and CCL generate income through non discretionary spending. In a recessionary environment this may favor lower cost competitors, but not always. Regardless, unlike a resource company, income will not decrease by a large amount and may increase in line with population growth independent of the general economy.
The other factor to consider is interest rates. We are likely to see interest rate drop to lows not seen before over the next few months. The search for yield will be again with CCL coming back into favor.

Anyway just a few thoughts.

Expand

Nice I've got wow and ccl. Rfg is another that did very well in the gfc (food) Have u considered slater Gordon? High risk but priced for failure, also counter cyclical stock.

CCL Price at posting: $8.45 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024

There are more pages in this discussion • 103 more messages in this thread...

First 5 Last

Add CCL (ASX) to my watchlist

Nice I've got wow and ccl. Rfg is another that did very well in...

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Cyclone signs MOU with Vale for development of Iron Bear play

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Banshee's historic trenches prove rich in antimony and gold for GDM

HotCopper Highlights: Your most watched stocks for Week 46, 2024